Drug-eluting versus third-generation bare metal stents: The US strategy

Daniel W. Isenbarger, Jon R. Resar

Research output: Contribution to journalReview articlepeer-review

8 Scopus citations


Drug-eluting stents have rapidly come to dominate the field of coronary intervention, constituting 85% of the US market just one year after introduction. The current utilization of bare metal stents in coronary intervention in the US is quite limited. This article will review technological advances in third-generation bare metal stents, which optimize procedural performance by means of improved flexibility, lower crossing profile, and thinner struts while maintaining fluoroscopic visibility and may portend a continued role for bare metal stents in some settings. This article will review data pertaining to outcomes with new generation bare metal stents and discuss current options for utilization of drug eluting stents versus bare metal stents in the US.

Original languageEnglish (US)
Pages (from-to)171-175
Number of pages5
JournalInternational Journal of Cardiovascular Interventions
Issue number4
StatePublished - Dec 1 2005


  • Bare metal stents
  • Coronary intervention
  • Drug-eluting stents

ASJC Scopus subject areas

  • Radiology Nuclear Medicine and imaging
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Drug-eluting versus third-generation bare metal stents: The US strategy'. Together they form a unique fingerprint.

Cite this